SCHEMBL3573052

SCHEMBL3573052

CCCCC1(Nc2ccccc2)CCC2(CC1)OCCO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 1/20 0.36
OPRM1 P35372 3/20 0.35
OPRL1 P41146 3/20 0.35
NR5A2 O00482 3/20 0.33
NR5A1 Q13285 3/20 0.33
ICMT O60725 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
GAA P10253 1/20 0.33
ELANE P08246 1/20 0.33
POLB P06746 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
NPC1 O15118 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3571850 0.77 MEN1 (0.39) ALDH1A1OPRM1OPRL1NR5A2NR5A1
SCHEMBL3563540 0.75 ALDH1A1 (0.40) ALDH1A1L3MBTL1TSHRGAAPOLB
SCHEMBL6045549 0.72 NPFFR1 (0.58) ALDH1A1TSHROPRM1OPRL1OPRD1
SCHEMBL3570982 0.70 OPRM1 (0.37) ALDH1A1OPRM1OPRL1MEN1KMT2A
SCHEMBL3570981 0.68 CSNK1E (0.40) ALDH1A1L3MBTL1TSHROPRM1OPRL1
SCHEMBL3573053 0.68 SLC6A4 (0.33) ALDH1A1L3MBTL1TSHROPRM1OPRL1
SCHEMBL14778726 0.65 OPRM1 (0.45) L3MBTL1TSHROPRM1OPRL1ELANE
SCHEMBL3927572 0.65 OPRM1 (0.49) ALDH1A1OPRM1OPRL1KMT2ASLC6A4
SCHEMBL7714540 0.64 ALDH1A1 (0.40) ALDH1A1L3MBTL1TSHRPOLBMEN1
Hydrochloric Acid SCHEMBL735730 0.64 OPRM1 (0.47) ALDH1A1OPRM1OPRL1KMT2ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121689-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-07-31 EP disclosed
US-8404740-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2013-03-26 US disclosed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
EP-2121689-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2009-11-25 EP disclosed
WO-2008101659-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048554-A1 Spirocyclic Cyclohexane Compounds OPRL1, OPRD1, OPRK1 ALDH1A1 588/4885L3MBTL1 1622/4885TSHR 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.